StemCell Therapy

Hearing loss affects 360 million people worldwide according to the World Health Organization. Inner ear sensory cells, called hair cells, are responsible for detecting sound and helping to signal it to the brain. Loud sounds and toxic drugs can lead to death of the hair cells, which do not regenerate, and is the root cause for widespread hearing loss. Until now, it was not possible to promote the generation of sufficient quantities of new hair cells.

In a new paper in Cell Reports, scientists from Brigham and Womens Hospital, Massachusetts Institute of Technology, and Massachusetts Eye & Ear describe a technique to grow large quantities of inner ear progenitor cells that convert into hair cells. The same techniques show the ability to regenerate hair cells in the cochlea.

Humans are born with only 15,000 sensory hair cells in each cochlea, which are susceptible to damage from exposure to loud noises and medications, which can lead to cell death and hearing loss over time.

Amazingly, birds and amphibians are capable of regenerating hair cells throughout their life, suggesting that the biology exists and should be possible for humans. Intrigued, we decided to explore whether these hair cells could be regenerated, says Jeff Karp, co-corresponding author and biomedical engineer at BWH.

"We took cochlear supporting cells expressing Lgr5, a marker recently found in stem cells of several organs, and treated them with a drug cocktail that stimulated critical pathways, says Xiaolei Yin, co-lead author on the paper and instructor of medicine at BWH. The team achieved a >2000-fold increase in Lgr5 progenitor cells and found that these progenitors could generate new hair cells in high yield. The team also demonstrated that this approach could work with cells from mouse, non-human primate, and human tissue.

Importantly, the drug cocktail generates new sensory hair cells in intact cochlear tissue, which shows promise for a therapy to treat patients with hearing loss, says Karp. This expansion of large populations of Lgr5-expressing cells and their differentiation to hair cells provides a powerful tool for investigating the regenerative biology of hearing, and these drugs should be relevant for clinical application.

To advance this work to patients, Frequency Therapeutics, is developing a novel small molecule approach to treat chronic hearing loss and expects to be in the clinic within the next 18 months.

Read the original here:
Scientists Unlock Ability to Generate New Sensory Hair Cells - Laboratory Equipment

This entry was posted on February 22, 2017 at 5:42 pm and is filed under Death by Stem Cells. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |